Caring for Chronic Kidney Disease Patients: Focus on Mineral and Bone Disorders
Abstract:This case study focuses on a patient with chronic kidney disease (CKD) with mineral and bone disorders (MBD) and the relationship and management strategies used in treating CKD-MBD. The various risks and issues pertaining to the CKD stage 5 patient population are addressed, including CKD-MBD and renal osteodystrophy. Proper management of CKD-MBD with diet, dialysis, laboratory testing, and medications is discussed. An interdisciplinary team that includes the patient and family is crucial for effective management of MBD.
Abbreviations: CKD = Chronic kidney disease, KDIGO = Kidney Disease Improving Global Outcomes, MBD = Mineral and bone disorders, NKF-KDOQI = National Kidney Foundation Kidney Disease Outcomes Quality Initiative, PTH = Parathyroid hormone, RO = Renal osteodystrophy, VDR = Vitamin D receptor.
Document Type: Research Article
Publication date: February 1, 2009
More about this publication?
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- ingentaconnect is not responsible for the content or availability of external websites